[Myelopid correction of immune deficiency in staffers exposed to lead materials at work].
Authors demonstrated that immune dysfunction of chronic lead intoxication is manifested in low number and changed subpopulations of immune cells, in alterations of spontaneous lymphocytes proliferation. "Myelopid" corrects the symptoms of immune dysfunction.
Stoliarov
I D
ID
Ogurtsov
R P
RP
Petrov
A M
AM
Votintseva
M V
MV
Ivashkova
E V
EV
Pestova
L A
LA
Elkina
V A
VA
D000276:Adjuvants, Immunologic / Q000008:administration & dosage / Q000627:therapeutic use*; D015703:Antigens, CD / Q000187:drug effects* / Q000276:immunology*; D006801:Humans; D007136:Immunoglobulins / Q000187:drug effects* / Q000276:immunology*; D007854:Lead / Q000009:adverse effects*; D007855:Lead Poisoning / Q000188:drug therapy / Q000453:epidemiology / Q000276:immunology; D009784:Occupational Diseases / Q000188:drug therapy / Q000453:epidemiology / Q000276:immunology; D009842:Oligopeptides / Q000008:administration & dosage / Q000627:therapeutic use*; D016896:Treatment Outcome
D000276:Adjuvants, Immunologic; D015703:Antigens, CD; D007136:Immunoglobulins; D009842:Oligopeptides; C048617:myelopeptides; D007854:Lead
Korretktsiia mielopidom immunodefitsita u sotrudnikov promyshlennogo predpriiatiia, rabotaiushchikh so svinetssoderzhashchimi materialami.